• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痘苗病毒SPI-2(B13R)基因产物对细胞凋亡的保护作用。

Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product.

作者信息

Dobbelstein M, Shenk T

机构信息

Howard Hughes Medical Institute, Department of Molecular Biology, Princeton University, New Jersey 08544-1014, USA.

出版信息

J Virol. 1996 Sep;70(9):6479-85. doi: 10.1128/JVI.70.9.6479-6485.1996.

DOI:10.1128/JVI.70.9.6479-6485.1996
PMID:8709286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190684/
Abstract

Vaccinia virus contains a gene, termed SPI-2 or B13R, that is closely related in its sequence to a potent inhibitor of apoptosis from cowpox virus (crmA). Infection by vaccinia virus protects HeLa cells against apoptosis that is induced by an immunoglobulin M antibody against the fas receptor or by tumor necrosis factor alpha. This effect is profoundly reduced when the SPI-2 gene is deleted. The SPI-2 gene, when transiently expressed in these cells, can also protect against apoptosis mediated by these agents. Given the similarity to crmA, it seems likely that SPI-2 functions in an analogous fashion, inhibiting the activity of ICE protease family members and blocking the onset of apoptosis.

摘要

痘苗病毒含有一个名为SPI-2或B13R的基因,其序列与来自牛痘病毒的一种有效的凋亡抑制剂(crmA)密切相关。痘苗病毒感染可保护HeLa细胞免受由抗fas受体的免疫球蛋白M抗体或肿瘤坏死因子α诱导的凋亡。当SPI-2基因缺失时,这种效应会大大降低。SPI-2基因在这些细胞中瞬时表达时,也可保护细胞免受这些因子介导的凋亡。鉴于与crmA的相似性,SPI-2似乎以类似的方式发挥作用,抑制ICE蛋白酶家族成员的活性并阻断凋亡的发生。

相似文献

1
Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product.痘苗病毒SPI-2(B13R)基因产物对细胞凋亡的保护作用。
J Virol. 1996 Sep;70(9):6479-85. doi: 10.1128/JVI.70.9.6479-6485.1996.
2
Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses.在感染牛痘病毒和兔痘病毒野生型以及CrmA/SPI-2突变体的猪肾细胞中半胱天冬酶的激活。
J Virol. 1998 May;72(5):3524-33. doi: 10.1128/JVI.72.5.3524-3533.1998.
3
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.痘苗病毒丝氨酸蛋白酶抑制剂B13R(SPI-2)可抑制白细胞介素-1β转化酶,并保护病毒感染的细胞免受肿瘤坏死因子和Fas介导的细胞凋亡,但不能预防白细胞介素-1β引起的发热。
J Gen Virol. 1997 Mar;78 ( Pt 3):677-85. doi: 10.1099/0022-1317-78-3-677.
4
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model.痘苗病毒丝氨酸蛋白酶抑制剂B13R(SPI-2)和B22R(SPI-1)编码分子量为38.5k和40k的细胞内多肽,在小鼠鼻内模型中这些多肽不影响病毒毒力。
Virology. 1995 Jan 10;206(1):136-47. doi: 10.1016/s0042-6822(95)80028-x.
5
Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product.
J Biol Chem. 1995 Feb 17;270(7):3255-60. doi: 10.1074/jbc.270.7.3255.
6
Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.正痘病毒融合抑制剂糖蛋白SPI-3(开放阅读框K2L)含有丝氨酸蛋白酶抑制剂的特征基序,这些基序对于控制细胞融合并非必需。
J Virol. 1995 Oct;69(10):5978-87. doi: 10.1128/JVI.69.10.5978-5987.1995.
7
The cowpox virus SPI-3 and myxoma virus SERP1 serpins are not functionally interchangeable despite their similar proteinase inhibition profiles in vitro.尽管牛痘病毒SPI-3和黏液瘤病毒SERP1丝氨酸蛋白酶抑制剂在体外具有相似的蛋白酶抑制谱,但它们在功能上不可互换。
Virology. 2000 Jul 5;272(2):281-92. doi: 10.1006/viro.2000.0378.
8
A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells.一种兔痘病毒丝氨酸蛋白酶抑制剂基因通过抑制限制性细胞中的凋亡来控制宿主范围。
J Virol. 1995 Dec;69(12):7688-98. doi: 10.1128/JVI.69.12.7688-7698.1995.
9
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.缺失丝氨酸蛋白酶抑制剂基因的减毒痘苗病毒载体诱导强大的体液免疫和细胞介导的免疫反应。
J Virol. 2004 Mar;78(6):2770-9. doi: 10.1128/jvi.78.6.2770-2779.2004.
10
Characterization of the ectromelia virus serpin, SPI-2.埃可病毒丝氨酸蛋白酶抑制剂SPI-2的特性分析
J Gen Virol. 2000 Oct;81(Pt 10):2425-2430. doi: 10.1099/0022-1317-81-10-2425.

引用本文的文献

1
Type I Interferon: Monkeypox/Mpox Viruses Achilles Heel?Ⅰ型干扰素:猴痘/猴疱疹病毒的阿喀琉斯之踵?
Adv Exp Med Biol. 2024;1451:125-137. doi: 10.1007/978-3-031-57165-7_8.
2
Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances.在后天花时代与牛痘病毒的相会:研发进展。
Viruses. 2023 Aug 15;15(8):1742. doi: 10.3390/v15081742.
3
Comparative genomics and integrated system biology approach unveiled undirected phylogeny patterns, mutational hotspots, functional patterns, and molecule repurposing for monkeypox virus.比较基因组学和综合系统生物学方法揭示了猴痘病毒无定向系统发育模式、突变热点、功能模式和分子再利用。
Funct Integr Genomics. 2023 Jul 11;23(3):231. doi: 10.1007/s10142-023-01168-z.
4
Genome-Wide Characterization and Comparative Genomic Analysis of the Serpin Gene Family in Microsporidian .微孢子虫丝氨酸蛋白酶抑制剂基因家族的全基因组特征和比较基因组分析
Int J Mol Sci. 2022 Dec 29;24(1):550. doi: 10.3390/ijms24010550.
5
How to Inhibit Nuclear Factor-Kappa B Signaling: Lessons from Poxviruses.如何抑制核因子-κB信号传导:来自痘病毒的经验教训
Pathogens. 2022 Sep 18;11(9):1061. doi: 10.3390/pathogens11091061.
6
Viral-mediated activation and inhibition of programmed cell death.病毒介导的细胞程序性死亡的激活和抑制。
PLoS Pathog. 2022 Aug 11;18(8):e1010718. doi: 10.1371/journal.ppat.1010718. eCollection 2022 Aug.
7
Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design.痘苗病毒:从粗糙的天花疫苗到精细的病毒载体疫苗设计
Biomedicines. 2021 Nov 26;9(12):1780. doi: 10.3390/biomedicines9121780.
8
Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?治疗诱导的肿瘤细胞死亡:免疫疗法的朋友还是敌人?
Front Oncol. 2021 Jun 1;11:678562. doi: 10.3389/fonc.2021.678562. eCollection 2021.
9
Poxviral Strategies to Overcome Host Cell Apoptosis.痘病毒克服宿主细胞凋亡的策略
Pathogens. 2020 Dec 23;10(1):6. doi: 10.3390/pathogens10010006.
10
Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool.使用CRISPR/Cas9作为筛选工具进行快速痘病毒工程改造。
Commun Biol. 2020 Nov 3;3(1):643. doi: 10.1038/s42003-020-01374-6.

本文引用的文献

1
An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif.一种带有类锌指基序的凋亡抑制杆状病毒基因。
J Virol. 1993 Apr;67(4):2168-74. doi: 10.1128/JVI.67.4.2168-2174.1993.
2
Prevention of vertebrate neuronal death by the crmA gene.crmA基因对脊椎动物神经元死亡的预防作用。
Science. 1994 Feb 11;263(5148):826-8. doi: 10.1126/science.8303301.
3
Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.白细胞介素-1β转化酶(一种与秀丽隐杆线虫细胞死亡基因ced-3同源的哺乳动物基因)诱导成纤维细胞凋亡。
Cell. 1993 Nov 19;75(4):653-60. doi: 10.1016/0092-8674(93)90486-a.
4
Multigenic evasion of inflammation by poxviruses.痘病毒对炎症的多基因逃避
J Virol. 1994 Mar;68(3):1737-49. doi: 10.1128/JVI.68.3.1737-1749.1994.
5
Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition.牛痘病毒丝氨酸蛋白酶抑制剂CrmA对白细胞介素-1β转化酶的抑制作用。跨类抑制的一个例子。
J Biol Chem. 1994 Jul 29;269(30):19331-7.
6
Linomide inhibits programmed cell death of peripheral T cells in vivo.
Eur J Immunol. 1994 Jan;24(1):48-52. doi: 10.1002/eji.1830240108.
7
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model.痘苗病毒丝氨酸蛋白酶抑制剂B13R(SPI-2)和B22R(SPI-1)编码分子量为38.5k和40k的细胞内多肽,在小鼠鼻内模型中这些多肽不影响病毒毒力。
Virology. 1995 Jan 10;206(1):136-47. doi: 10.1016/s0042-6822(95)80028-x.
8
Delay of vaccinia virus-induced apoptosis in nonpermissive Chinese hamster ovary cells by the cowpox virus CHOhr and adenovirus E1B 19K genes.牛痘病毒CHOhr基因和腺病毒E1B 19K基因延缓痘苗病毒在非允许性中国仓鼠卵巢细胞中诱导的凋亡
J Virol. 1995 Feb;69(2):661-8. doi: 10.1128/JVI.69.2.661-668.1995.
9
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.Yama/CPP32β,一种CED-3的哺乳动物同源物,是一种可被CrmA抑制的蛋白酶,它能切割死亡底物聚(ADP-核糖)聚合酶。
Cell. 1995 Jun 2;81(5):801-9. doi: 10.1016/0092-8674(95)90541-3.
10
Viruses and apoptosis.病毒与细胞凋亡
Curr Opin Genet Dev. 1995 Feb;5(1):105-11. doi: 10.1016/s0959-437x(95)90061-6.